Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Pancreatic Adenocarcinoma × Gemcitabine × Clear all

Phase

Phase 2 5 Phase 3 2 Phase EARLY_PHASE1 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5 Pancreatic Adenocarcinoma 1 Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Lymphoma, B-Cell 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Interleukin 1 Receptor Antagonist Protein 1 Gemcitabine 1 Cisplatin 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02550327 2021-06-22

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Baylor Research Institute

Phase EARLY_PHASE1 Completed

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡